PROKIDNEY CORP (PROK) Stock Analyst Ratings
NASDAQ:PROK - Nasdaq - KYG7S53R1049 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to PROK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 240% above the current price.
PROK was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about PROK.
In the previous month the buy percentage consensus was at a similar level.
PROK was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-30 | JP Morgan | Initiate | Neutral |
| 2024-09-10 | Guggenheim | Initiate | Buy |
| 2024-09-04 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-06-10 | Jefferies | Maintains | Buy -> Buy |
| 2024-05-29 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-01-02 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-07-25 | BTIG | Initiate | Buy |
| 2022-12-21 | Jefferies | Initiate | Buy |
| 2022-11-10 | Morgan Stanley | Initiate | Equal-Weight |
| 2022-10-18 | UBS | Initiate | Buy |
| 2022-10-14 | Citigroup | Initiate | Buy |
| 2022-09-02 | Evercore ISI Group | Initiate | Outperform |